ATLAS VENTURE FUND V LP's Net Worth
$1.93 Million
Who is ATLAS VENTURE FUND V LP?
ATLAS VENTURE FUND V LP has an estimated net worth of $1.93 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS INC, Isilon Systems, Inc., Phase Forward Inc, ACHILLION PHARMACEUTICALS INC, NxStage Medical, Inc., MOMENTA PHARMACEUTICALS INC, and HELICOS BIOSCIENCES CORP.
SEC CIK
ATLAS VENTURE FUND V LP's CIK is 0001106910
Past Insider Trading and Trends
2004 was ATLAS VENTURE FUND V LP's most active year for acquiring shares with 28 total transactions. ATLAS VENTURE FUND V LP's most active month to acquire stocks was the month of May. 2005 was ATLAS VENTURE FUND V LP's most active year for disposing of shares, totalling 27 transactions. ATLAS VENTURE FUND V LP's most active month to dispose stocks was the month of May. 2004 saw ATLAS VENTURE FUND V LP paying a total of $2,670,000.00 for 5,909,079 shares, this is the most they've acquired in one year. In 2006 ATLAS VENTURE FUND V LP cashed out on 91,500 shares for a total of $1,364,780.41, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALNYLAM PHARMACEUTICALS INC (ALNY) Snapshot price: $246.78
InvestorATLAS VENTURE FUND V LP owns 13,095 units of Common Stock which is worth $3,231,584.10. In the year 2004 ATLAS VENTURE FUND V LP filed a total of 6 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.84% | -183.00K |
$14.97 | -$2,729,560.81 | 2.49M |
Feb 23 - Feb 24
| |||
Form 4
| -33.33% | -1.34M |
—
|
—
| 2.67M |
Sep 29
| |||
Form 4
| +801.66% | 3.57M |
—
|
—
| 4.01M |
Jun 3
| |||
Form 4/A
|
∞
| 445K |
$6.00 | $2,670,000.00 | 445K |
May 27
| |||
Form 4
|
∞
| 445K |
$6.00 | $2,670,000.00 | 445K |
May 27 - Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Isilon Systems, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -12.82M |
$33.85 | -$433,858,496.50 |
0
|
Dec 17
| |||
Form 4
| -2.38% | -313.00K |
$20.07 | -$6,280,381.60 | 12.82M |
Aug 23 - Aug 24
| |||
Form 4
| -3.28% | -445.00K |
$17.52 | -$7,794,231.10 | 13.13M |
Aug 16 - Aug 18
| |||
Form 4
| -2.31% | -320.29K |
$17.97 | -$5,756,261.51 | 13.58M |
Aug 4 - Aug 6
| |||
Form 4
| -3.10% | -444.70K |
$17.93 | -$7,973,305.73 | 13.9M |
Jul 30 - Aug 3
| |||
Form 4
| -1.98% | -289.81K |
$17.40 | -$5,041,885.59 | 14.34M |
Jul 26 - Jul 27
| |||
Form 4
| -1.82% | -271.70K |
$14.48 | -$3,933,741.79 | 14.63M |
May 11 - May 13
| |||
Form 4
| -1.00% | -150.00K |
$14.17 | -$2,125,785.00 | 14.9M |
May 4 - May 5
| |||
Form 4
| +0.23% | 69.28K |
$3.40 | $233,317.78 | 30.1M |
Nov 13 - Nov 14
| |||
Form 4
| +0.30% | 135.9K |
$3.41 | $461,815.74 | 44.95M |
Nov 10 - Nov 12
| |||
Form 4
| +0.09% | 25.44K |
$3.45 | $87,506.63 | 29.69M |
Nov 6 - Nov 7
| |||
Form 4
| +0.14% | 42.81K |
$3.42 | $145,049.54 | 29.64M |
Nov 4 - Nov 5
| |||
Form 4
|
∞
| 14.78M |
—
|
—
| 14.78M |
Dec 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Phase Forward Inc No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -36.45% | -1.25M |
—
|
—
| 2.18M |
Oct 10
| |||
Form 4
| -5.25% | -190.00K |
$8.97 | -$1,704,300.00 | 3.43M |
Sep 14
| |||
Form 4
| -1.87% | -138.29K |
$8.46 | -$1,169,767.24 | 7.24M |
Sep 9 - Sep 12
| |||
Form 4
| -1.46% | -111.71K |
$8.27 | -$924,300.52 | 7.52M |
Sep 7 - Sep 8
| |||
Form 4
| -1.15% | -45.00K |
$7.61 | -$342,450.00 | 3.87M |
Jun 14
| |||
Form 4
| -1.26% | -50.00K |
$6.93 | -$346,500.00 | 3.91M |
Jun 9
| |||
Form 4
| -1.28% | -154.62K |
$6.82 | -$1,054,507.00 | 11.89M |
Jun 6 - Jun 8
| |||
Form 4
| -10.82% | -500.00K |
$6.85 | -$3,425,000.00 | 4.12M |
Mar 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACHILLION PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.97M |
—
|
—
| 1.97M |
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NxStage Medical, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||